Mato, A. R., Woyach, J. A., Brown, J. R., Ghia, P., Patel, K., Eyre, T. A., Munir, T., Lech-Maranda, E., Lamanna, N., Tam, C. S., Shah, N. N., Coombs, C. C., Ujjani, C. S., Fakhri, B., Cheah, C. Y., Patel, M. R., Alencar, A. J., Cohen, J. B., Gerson, J. N., … Jurczak, W. (2023). Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia. New England Journal of Medicine, 389(1), 33–44. https://doi.org/10.1056/nejmoa2300696
Subjects:
Antineoplastic Agents
(MeSH)
Protein Kinase Inhibitors
(MeSH)
Publication Type:
Article
Unique ID:
10.1056/nejmoa2300696
PMID:
Journal:
Publication Date:
Data Source:
PubMed
Source Link: